LUMO Lumos Pharma
- 3.950
- +0.020+0.51%
- 3.950
- 0.0000.00%
Lumos Pharma News
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Lawley Lori D
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer McKew John C.
Lumos Pharma | 10-Q: Q2 2024 Earnings Report
Lumos Pharma | 8-K: Lumos Pharma Reports Second Quarter 2024 Financial Results and Provides Clinical Development Update
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director van Es-Johansson An
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director LALANDE KEVIN M.
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director Raffin Thomas A.
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director Zoth Lota S.
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director JOHNSON CHAD ALLEN
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Director McCracken Joseph S
Lumos Pharma | 8-K: Current report
Lumos Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Pitukcheewanont Pisit Duke
Lumos Pharma | 10-Q: Q1 2024 Earnings Report
Lumos Pharma | 8-K: Lumos Pharma Announces Positive End-of-Phase 2 Meeting with FDA and Reports First Quarter 2024 Financial Results
Lumos Pharma | 10-K/A: Annual report (Amendment)
Lumos Pharma | 8-K: Current report
Lumos Pharma | ARS: Annual Report to Security Holders
Lumos Pharma | DEFA14A: Others
Analysis
Price Target
No Data
